PGEN Precigen, Inc.
Healthcare$4.24+0.00%ClosedMarket Cap: $1.27B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
65.58
P/S
40.32
EV/EBITDA
-15.81
DCF Value
$-0.30
FCF Yield
-9.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
75.6%
Operating Margin
-297.2%
Net Margin
-647.0%
ROE
-1768.5%
ROA
-147.5%
ROIC
-79.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $23.3M | 87.6% | $-6.0M | $-7.9M | $— | — |
| Q4 null | $4.6M | 58.1% | $-21.7M | $-23.5M | $— | — |
| FY null | $9.7M | 37.1% | $-106.6M | $-250.6M | $— | — |
| Q3 null | $2.9M | 53.7% | $-34.5M | $-146.3M | $— | — |
| Q2 null | $856.0K | -81.7% | $-31.8M | $-26.6M | $— | — |
| Q1 null | $1.3M | -5.8% | $-22.6M | $-54.2M | $— | — |
| Q4 null | $1.2M | 1.8% | $-28.5M | $-19.7M | $— | — |
| FY null | $3.9M | -8.7% | $-135.0M | $-126.2M | $— | — |
| Q3 null | $953.0K | -5.9% | $-21.3M | $-24.0M | $— | — |
| Q2 null | $717.0K | -41.4% | $-60.8M | $-58.8M | $— | — |
| Q1 null | $1.1M | -76.1% | $-24.4M | $-23.7M | $— | — |
| Q4 2023 | $1.2M | -109.0% | $-23.4M | $-33.1M | $-0.13 | — |